Bacterial ribosome — Drug Target

All drugs that target Bacterial ribosome — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Bacterial protein synthesis inhibitor

Phase 3 pipeline (1)

• CB-183,315 · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · Bacterial protein synthesis inhibitor · Infectious Disease
  CB-183,315 is a selective inhibitor of bacterial protein synthesis that targets gram-positive pathogens by binding to the bacterial ribosome.